361 related articles for article (PubMed ID: 25681658)
1. HIF targets in bone remodeling and metastatic disease.
Johnson RW; Schipani E; Giaccia AJ
Pharmacol Ther; 2015 Jun; 150():169-77. PubMed ID: 25681658
[TBL] [Abstract][Full Text] [Related]
2. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia and Bone Metastatic Disease.
Johnson RW; Sowder ME; Giaccia AJ
Curr Osteoporos Rep; 2017 Aug; 15(4):231-238. PubMed ID: 28597139
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic Microenvironment and Metastatic Bone Disease.
Hiraga T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.
Wu C; Rankin EB; Castellini L; Alcudia JF; LaGory EL; Andersen R; Rhodes SD; Wilson TL; Mohammad KS; Castillo AB; Guise TA; Schipani E; Giaccia AJ
Genes Dev; 2015 Apr; 29(8):817-31. PubMed ID: 25846796
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA; Ohh M
Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
[TBL] [Abstract][Full Text] [Related]
9. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel VHL target genes and relationship to hypoxic response pathways.
Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability.
Park MH; Choi KY; Jung Y; Min do S
Oncotarget; 2014 Dec; 5(23):11857-72. PubMed ID: 25361009
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of HIF-1A and its implication in the hypoxia pathway in primary advanced uterine cervical carcinoma.
Łuczak MW; Roszak A; Pawlik P; Kędzia H; Lianeri M; Jagodziński PP
Oncol Rep; 2011 Nov; 26(5):1259-64. PubMed ID: 21887475
[TBL] [Abstract][Full Text] [Related]
15. Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.
Roberts AM; Ohh M
Curr Opin Oncol; 2008 Jan; 20(1):83-9. PubMed ID: 18043261
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
17. n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems.
Kimura M; Takabuchi S; Tanaka T; Murata M; Nishi K; Oda S; Oda T; Kanai M; Fukuda K; Kizaka-Kondoh S; Adachi T; Takabayashi A; Semenza GL; Hirota K
Biochem J; 2008 Apr; 411(1):97-105. PubMed ID: 18047470
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
20. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
Yu F; White SB; Zhao Q; Lee FS
Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
